113 related articles for article (PubMed ID: 7384559)
21. Metabolism of linoleic and arachidonic acids in VX2 carcinoma tissue: identification of monohydroxy octadecadienoic acids and monohydroxy eicosatetraenoic acids.
Hubbard WC; Hough AJ; Brash AR; Watson JT; Oates JA
Prostaglandins; 1980 Sep; 20(3):431-47. PubMed ID: 6775354
[TBL] [Abstract][Full Text] [Related]
22. Plasma prostaglandins in hypercalcemic patients with neoplastic disease.
Demers LM; Allegra JC; Harvey HA; Lipton A; Luderer JR; Mortel R; Brenner DE
Cancer; 1977 Apr; 39(4):1559-62. PubMed ID: 851945
[TBL] [Abstract][Full Text] [Related]
23. [Esophageal carcinoma with hypercalcemia that appeared to be caused by prostaglandin E2 produced by the tumor cells].
Maeda Y; Sasaki T; Mochizuki M; Koike M
Gan No Rinsho; 1990 Nov; 36(14):2445-9. PubMed ID: 2250367
[TBL] [Abstract][Full Text] [Related]
24. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors.
Wright KC; Yang P; Van Pelt CS; Hicks ME; Collin P; Newman RA
J Exp Ther Oncol; 2005; 5(1):55-68. PubMed ID: 16416602
[TBL] [Abstract][Full Text] [Related]
26. Arachidonic acid metabolites in a nephroblastoma associated with paraneoplastic hypercalcemia.
Calò L; Cantaro S; Vianello A; Vido L; Rizzoni G; Borsatti A
Prostaglandins; 1986 Jul; 32(1):116-20. PubMed ID: 3020618
[TBL] [Abstract][Full Text] [Related]
27. Systemic effects of the VX2 carcinoma on the osseous skeleton. A quantitative study of trabecular bone.
Wolfe HJ; Bitman WR; Voelkel EF; Griffiths HJ; Tashjian AH
Lab Invest; 1978 Feb; 38(2):208-15. PubMed ID: 628205
[TBL] [Abstract][Full Text] [Related]
28. Hypercalcemia in a case of childhood acute lymphoblastic leukemia.
Todo S; Imashuku S; Inoda H; Yamanaka H; Hibi S; Tsunamoto K; Esumi N; Fujiwara F; Shimizu Y; Morioka Y
Jpn J Clin Oncol; 1987 Dec; 17(4):357-62. PubMed ID: 3320403
[TBL] [Abstract][Full Text] [Related]
29. Effects of prostaglandin on experimental bone malignancy and on scintigrams of bone and marrow.
Otsuka N; Ito Y; Nagai K; Terashima H; Yanagimoto S; Muranaka A
J Nucl Med; 1981 May; 22(5):433-40. PubMed ID: 6452515
[TBL] [Abstract][Full Text] [Related]
30. Ultrastructural and histomorphometric evaluations of gallium nitrate on bone in nude mice bearing a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Okada H; Merryman JI; Capen CC; Rosol TJ
Vet Pathol; 1995 Jan; 32(1):36-42. PubMed ID: 7725596
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of immune function and tumor growth inhibition by antibodies against prostaglandin E2.
Young MR; Dizer M
Immunol Commun; 1983; 12(1):11-23. PubMed ID: 6573300
[TBL] [Abstract][Full Text] [Related]
32. Plasma prostaglandin levels and circulating fuel levels in rats with diabetic ketoacidosis: effects of cyclooxygenase inhibitors and of alpha and beta adrenergic blockade.
Axelrod L; Cornelius P
Prostaglandins; 1984 Sep; 28(3):333-52. PubMed ID: 6440213
[TBL] [Abstract][Full Text] [Related]
33. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy.
Brenner DE; Harvey HA; Lipton A; Demers L
Cancer; 1982 Feb; 49(3):556-61. PubMed ID: 7059914
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandins and hypercalcemic states.
Seyberth HW; Raisz LG; Oates JA
Annu Rev Med; 1978; 29():23-9. PubMed ID: 348034
[TBL] [Abstract][Full Text] [Related]
35. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
Young MR; Wheeler E; Newby M
J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
[TBL] [Abstract][Full Text] [Related]
36. [A comparison of three methods in establishing transplanted model of VX2 tongue carcinoma in rabbits].
Tian J; Liao GQ; Liu HC; Li CZ; Li Q; Wang JX; Du RC; Zhang TH
Hua Xi Kou Qiang Yi Xue Za Zhi; 2009 Jun; 27(3):326-9. PubMed ID: 19637489
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
[TBL] [Abstract][Full Text] [Related]
38. Changes in bone and bone marrow of rabbits bearing the VX-2 carcinoma. A comparison of local and distant effects.
Hough A; Seyberth H; Oates J; Hartmann W
Am J Pathol; 1977 Jun; 87(3):537-52. PubMed ID: 869013
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a radioimmunoassay for prostaglandin E2 metabolite levels in plasma.
Demers LM; Brennecke SP; Mountford LA; Brunt JD; Turnbull AC
J Clin Endocrinol Metab; 1983 Jul; 57(1):101-6. PubMed ID: 6853670
[TBL] [Abstract][Full Text] [Related]
40. Experimental study of paraplegia caused by spinal tumors: an animal model of spinal tumors created by transplantation of VX2 carcinoma.
Takahashi M; Ogawa J; Kinoshita Y; Takakura M; Mochizuki K; Satomi K
Spine J; 2004; 4(6):675-80. PubMed ID: 15541702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
